"Northside Hospital-Atlanta (in Sandy Springs) opened in 1970. The original facility had 250 beds and has since been expanded to 537 beds."

During the past decade, Northside Hospital conducted 194 clinical trials. In the 10-year time frame, 194 clinical trials started and 123 clinical trials were completed, i.e. on average, 63.4% percent of trials that started reached the finish line to date. In the past 5 years, 74 clinical trials started and 81 clinical trials were completed. i.e. 109.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northside Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Northside Hospital, Inc." with 15 trials sponsored, "NRG Oncology" with 11 trials sponsored and "Alliance for Clinical Trials in Oncology" with 11 trials sponsored. Other sponsors include 160 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northside Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 83 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 8 trials as a collaborator and "Canadian Cancer Trials Group" with 7 trials as a collaborator. Other collaborators include 108 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Northside Hospital" are "Acute Myeloid Leukemia" (16 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Multiple Myeloma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Stage IV Lung Cancer AJCC v8" (10 trials). Many other conditions were trialed in "Northside Hospital" in a lesser frequency.

Most popular intervention types in "Northside Hospital" are "Drug" (215 trials), "Other" (121 trials), "Biological" (89 trials), "Procedure" (38 trials) and "Radiation" (27 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (67 trials), "Quality-of-Life Assessment" (44 trials), "Paclitaxel" (33 trials), "Carboplatin" (29 trials) and "Placebo" (27 trials). Other intervention names were less common.

The vast majority of trials in "Northside Hospital" are 225 trials for "All" genders, 64 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Northside Hospital". 1 are not yet recruiting, 60 are recruiting, 106 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in Northside Hospital, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Northside Hospital, 32 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 137 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 14 trials that are defined as “Not Applicable".